MIG
JUNO

Mariner Investment Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Mariner Investment Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-24,000
Closed -$66K – 253
2015
Q2 		$66K Buy
+24,000
New +$1.27M 0.02% 187

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Mariner Investment Group's JUNO Position: Q3 2016 in Review

Mariner Investment Group sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2016, closing a stake of 17,700 shares — an estimated $680K sold.

Mariner Investment Group first reported a position in JUNO in Q4 2014 and held it in 7 quarters. The position peaked at $1.71M in Q4 2014. 169 funds tracked by Wall St. Rank hold JUNO as of Q3 2016.

  • Mariner Investment Group reported no remaining Juno Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 17,700 Juno Therapeutics, Inc. shares in Q3 2016, an estimated $680K.
  • Mariner Investment Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
  • Mariner Investment Group's Juno Therapeutics, Inc. position peaked at $1.71M in Q4 2014.
  • 169 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.